跳至主要内容
临床试验/NCT02303353
NCT02303353Unknown不适用

Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy

SPGO Research Mannheim GmbH1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,000
试验地点
1
主要终点
Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation)

研究概览

简要总结

The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • Tumor disease (carcinoma of either breast, ovary, lung, colon, stomach, pancreas, rectum or plasmacytoma)
  • Written informed consent

排除标准

  • 未提供

结局指标

主要结局

Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation)

时间窗: From date of ICF until date of cure/death/ICF withdrawal, up to 60 months

Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation

次要结局

  • Adverse reactions and their treatment (Number and type of adverse reactions and applied counter measures / therapies)(From date of ICF until date of cure/death/ICF withdrawal, up to 60 months)

研究者

发起方
SPGO Research Mannheim GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验